Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT [Phase 1]
Phase 1 trial exploring a calcineurin inhibitor-free graft-versus-host disease prevention regimen after related haploidentical peripheral bl…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma [Phase 2]
Phase 2 trial evaluating ROAD regimen (Oxaliplatin, Cytarabine, Dexamethasone) with Rituxan in relapsed non-Hodgkin lymphoma; trial complete…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Allo-hNHL (FluBuCy) [Phase 2]
Phase 2 clinical trial update for Allo-hNHL (FluBuCy) in Non-Hodgkin's Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL [Phase 1, Phase 2]
Phase 1/2 trial evaluating VSLI plus rituximab in relapsed/refractory non-Hodgkin lymphoma, including diffuse large B-cell lymphoma and mant…
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transpla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Tenofovir to Prevent HBV Reactivation [Phase 3]
Phase 3 clinical trial update on using tenofovir to prevent hepatitis B reactivation in patients with hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 2]
Phase 2 trial investigating sirolimus, cyclosporine, and mycophenolate mofetil to prevent graft-versus-host disease in patients with blood c…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial assessing donor atorvastatin to prevent severe acute GVHD after nonmyeloablative peripheral blood stem cell transplan…
-
FDA approval · 2019-11-21FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)
The FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) submitted by Cephalon, LLC.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating lenalidomide after chemotherapy and stem cell transplant in various forms of recurrent or resistant no…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL [Phase 4]
Phase 4 trial investigating a PD-1 monoclonal antibody in combination with chemotherapy for relapsed/refractory non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating peripheral stem cell transplantation with combination chemotherapy in low-grade non-Hodgkin's lymphoma or chronic l…
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial investigating lenalidomide and temsirolimus in relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma across Phase …
-
FDA label_change · 2019-10-08FDA Approved: BENDEKA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Bendeka (bendamustine hydrochloride) by Teva Pharmaceuticals to update its labeling.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Rituximab and NK Immunotherapy for B Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the combination of Rituximab with NK cell immunotherapy for recurrent B-cell lymphoma has completed.
-
CLINICAL_TRIALS research · 2019-09-10Clinical Trial Update: Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma [Phase 4]
Phase 4 cost-effectiveness study evaluating PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in lymphoma.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19 [Phase 1, Phase 2]
Clinical trial update for TriCAR-T_CD19 in refractory/relapsed non-Hodgkin lymphoma (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS research · 2019-09-06Clinical Trial Update: Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
Clinical trial assessing electrophysiological biomarkers of chemotherapy-related cognitive impairment and recovery; study completed with pos…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study [Phase 1, Phase 2]
An extension study of idelalisib (GS-1101) in subjects who benefited from prior idelalisib therapy; study terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL [Phase 2]
Phase 2 trial update for rituximab, yttrium Y-90 ibritumomab tiuxetan in relapsed follicular non-Hodgkin lymphoma (stages II-IV).
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL [Phase 1, Phase 2]
Phase I/II trial investigating redox regulation in relapsed or refractory CD20+ non-Hodgkin's lymphoma has been terminated with results post…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) [Phase 3]
Phase 3 trial update for rituximab plus lenalidomide in relapsed/refractory indolent non-Hodgkin lymphoma (follicular lymphoma and marginal …
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab [Phase 3]
A Phase 3 trial comparing maintenance subcutaneous rituximab to observation in relapsed/refractory indolent non-Hodgkin's lymphoma after rit…
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Molecular and Whole-body MR Imaging in Lymphomas [NA]
Completed clinical trial investigating molecular and whole-body MRI imaging methods in lymphoma patients; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating chemotherapy in combination with inotuzumab ozogamicin in subjects with B-cell lymphoma (non-Hodgkin's lymphoma) ha…